Se préparer à la hausse des cancers des adultes jeunes

Information

Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

Plateforme PETRA - publications

back to job offer list

back to clinical trials

Plateforme PETRA : Publications

TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
(RT036.22) IF : 29,7

02/18/2025

Fanny Jaulin reçoit le Prix du Palmarès des Inventeurs en santé du magazine Le Point

Depuis 2022, le magazine Le Point met chaque année à l'honneur des scientifiques français dont les recherches « changent nos vies ». Pour l'édition 2025, le jury – composé de deux Prix Nobel, de dirigeants d'entreprises et de personnalités du monde académique – a distingué les travaux de deux chercheuses de Gustave Roussy : Fanny Jaulin et la Pr...

Améliorer les traitements pédiatriques grâce à l’impression 3D

back to job offer list

back to clinical trials

Villejuif, le 11 février 2025

02/11/2025

Take part in the 4th edition of the Transatlantic Exchanges dedicated to radioligand therapies

Gustave Roussy and the Dana-Farber Cancer Institute (Boston, United States) are organising the fourth edition of the Transatlantic Exchange oncology conference on 19 March 2025 at the Hyatt Regency Paris Étoile hotel. The theme will be “Radiopharmaceutical Therapy Meets Oncology.”

The Lancet - bénéfices de la radiothérapie interne vectorisée chez les patients atteints d’un cancer de la prostate métastatique

back to job offer list

back to clinical trials

30 décembre 2024

Cellules allo-CAR-T : un pas de plus vers des thérapies cellulaires standardisées et accessibles

back to job offer list

back to clinical trials

30 janvier 2025

OASIS, a new European research programme to optimise antibody-drug conjugates

back to job offer list

back to clinical trials

Logos partenaires

Villejuif, February 6, 2025

02/04/2025

The President of the French Republic lays the foundation stone for Gustave Roussy’s new research building

The laying of the foundation stone marks a decisive milestone in developing the Paris-Saclay Cancer Cluster, which is currently being established around Gustave Roussy and is set to become the largest oncology hub in Europe.

Resilience and the Department of Therapeutic Innovation and Early Stage Trials are leveraging remote patient monitoring for clinical research in oncology

back to job offer list

back to clinical trials

Paris, the 3rd of February 2025

02/03/2025